Strategies for Pharmacist Involvement in Adverse Effect Management | PTCE Pharmacy Connect

Educational Objectives
·            Recognize best practices for managing adverse effects associated with immune checkpoint inhibitor (ICI)-targeted therapy combinations
 
Faculty:
Jacob K. Kettle, PharmD, BCOP
Pharmacy Manager
Ellis Fischel Cancer Center
Department of Pharmacy
University of Missouri Health Care
Columbia, Missouri
 
Faculty, has the following financial relationships with commercial interests to disclose:
Jacob Kettle, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:
Speakers Bureau: Genentech, Merck, Amgen, Lilly, DSI
Consultant: Pfizer, Lilly

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.075 CEU) under the ACPE universal activity number 0290-0000-21-438-H01-P. The activity is available for CE credit through December 17, 2022.
This activity is supported by educational grants from Eisai Inc and Exelixis, Inc.
Learn more about your ad choices. Visit megaphone.fm/adchoices